Novavax, Inc. (BMV:NVAX)

Novavax Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,324	26,836	9,640	17,241	221,759	81,162
Market Cap Growth	-21.67%	178.39%	-44.09%	-92.22%	173.23%	4510.87%
Enterprise Value	18,200	13,348	3,018	5,861	191,455	84,178
Last Close Price	155.16	167.00	81.41	200.00	2936.67	2220.00
PS Ratio	1.24	1.89	0.58	0.45	9.44	8.58
PB Ratio	35.69	-2.06	-0.79	-1.39	-30.76	6.50
P/TBV Ratio	-	-	-	-	-	8.39
P/FCF Ratio	-	-	-	-	40.30	-
P/OCF Ratio	-	-	-	-	33.50	-
EV/Sales Ratio	0.91	0.94	0.18	0.15	8.15	8.90
EV/FCF Ratio	-1.52	-	-	-	34.79	-
Debt / Equity Ratio	6.07	-0.42	-0.39	-0.97	-1.49	0.77
Debt / FCF Ratio	-	-	-	-	1.95	-
Asset Turnover	0.68	0.41	0.49	0.82	0.55	0.54
Inventory Turnover	47.59	22.59	26.47	90.94	-	-
Quick Ratio	2.15	0.89	0.53	0.58	0.82	1.68
Current Ratio	2.36	0.98	0.70	0.69	0.90	2.15
Return on Equity (ROE)	-	-	-	-	-1265.71%	-189.60%
Return on Assets (ROA)	14.52%	-8.63%	-17.02%	-16.67%	-50.69%	-29.48%
Return on Capital (ROIC)	467.59%	-	-	-519.71%	-164.51%	-41.57%
Earnings Yield	31.49%	-14.56%	-95.59%	-74.44%	-16.12%	-10.25%
FCF Yield	-47.34%	-7.79%	-134.64%	-57.14%	2.48%	-2.38%
Buyback Yield / Dilution	-30.54%	-51.03%	-28.89%	-5.08%	-29.27%	-138.81%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.